CD4+ Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice
CD4+ Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice
复制标题
DOI:
10.1172/jci8922
复制
发表时间:
2000-06-01
影响因子:
15.9
通讯作者:
Ikeda, S
中科院分区:
文献类型:
--
作者:
Ikehara, Y;Yasunami, Y;Ikeda, S
Pancreatic islet transplantation represents a potential treatment for insulin-dependent diabetes mellitus. However, the precise cellular and molecular mechanisms of the immune reactions against allogeneic and xenogeneic transplanted islets remain unclear. Here, we demonstrate that CD4(+) V alpha 14 natural killer T (NKT) cells, a recently identified lymphoid cell lineage, are required for the acceptance of intrahepatic rat islet xenografts. An anti-CD4 mAb, administrated after transplantation, allowed islet xenografts to be accepted by C57BL/6 mice, with no need for immunosuppressive drugs. The dose of anti-CD4 mAb was critical, and the beneficial effect appeared to be associated with the reappearance of CD4(+) NKT cells at around 14 days after transplantation Interestingly, rat islet xenografts were rejected, despite the anti-CD4 mAb treatment, in V alpha 14 NKT cell-deficient mice, which exhibit the normal complement of conventional lymphoid cells; adoptive transfer of Ver 14 NKT cells into Vee 14 NKT cell-deficient mice restored the acceptance of rat islet xenografts. In addition, rat islet xenografts were accepted by V alpha 14 NKT mice having only Va14 NKT cells and no other lymphoid cells. These results indicate that V alpha 14 NKT cells play a crucial role in the acceptance of rat islet xenografts in mice treated with anti-CD4 antibody, probably by serving as immunosuppressive regulatory cells.